secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABEONA THERAPEUTICS INC. (ABEO)
CIK:        0000318306
Form:       8-K
Filed at:   2022-03-09T23:59:59+00:00
Accession:  0001493152-22-006398
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Abeona Therapeutics CFO Edward Carr resigns; Joseph Vazzano appointed new CFO
-----------------------------------------------------------------------------

- Edward Carr resigns effective March 31, 2022; no disagreement with company.
- Joseph Vazzano appointed CFO effective March 14, 2022; previously CFO of Avenue Therapeutics (ATXI).
- Vazzano receives $360k base salary, 40% target bonus, 200k restricted shares; potential increase to $400k salary.
- Vazzano to become principal financial and accounting officer on March 31, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318306/000149315222006398/0001493152-22-006398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318306/000149315222006398/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-006398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer